Form 4: Thermo Fisher Scientific Director Karen S. Lynch Reports Stock Transactions

Director Karen S. Lynch reports acquisition and disposal of Thermo Fisher Scientific Inc. common stock.

Summary

• On May 21, 2025, Karen S. Lynch, a director of Thermo Fisher Scientific Inc., reported a transaction involving the company's common stock.
• Lynch acquired 565 shares of common stock at a price of $0.
• Lynch disposed of 660 shares of common stock.
• Following the reported transactions, Lynch directly owns 76 shares of common stock and indirectly owns shares through a living trust.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing, reflecting standard stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, as insider trading activity is often monitored for signals about company performance.

Key Dates

Keywords

Form 4, Thermo Fisher Scientific, Director, Stock Transaction, Beneficial Ownership, Karen S. Lynch, TMO